Tag: Blueprint Medicines Corp

Home / Blueprint Medicines Corp

Categories

Avapritinib has been approved by the FDA for advanced systemic mastocytosis

August 2021: The FDA approved avapritinib (AyvakitTM, Blueprint Medicines Corp.) for adult patients with advanced systemic mastocytosis (AdvSM), which includes aggressive systemic mastocytosis (ASM), ...
blueprint-medicines-corp

Scan the code